Immunoclin (Immunoclin) Marketable Securities : $0.00 Mil (As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Immunoclin's Marketable Securities for the quarter that ended in Oct. 2014 was $0.00 Mil.

Immunoclin Marketable Securities Historical Data

The historical data trend for Immunoclin's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Marketable Securities Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Marketable Securities

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Marketable Securities	Get a 7-Day Free Trial									-	-	-	-	-

Immunoclin Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Immunoclin (GREY:IMCL) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Immunoclin Marketable Securities Related Terms

Thank you for viewing the detailed overview of Immunoclin's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines